Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease

Authors

Mohamed Elagawany, Damanhour University
Ayman Abo Elmaaty, Port Said University
Ahmed Mostafa, Justus-Liebig University Giessen
Noura M Abo Shama, National Research Centre
Eman Y Santali, Taif University
Bahaa Elgendy, Washington University School of Medicine in St. Louis
Ahmed A Al-Karmalawy, Horus University-Egypt

Journal

Journal of Enzyme Inhibition and Medicinal Chemistry

Publication Date

7-31-2022

Volume

37

Issue

1

First Page

2112

Last Page

2132

Document Type

Open Access Publication

DOI

10.1080/14756366.2022.2105322

Rights and Permissions

Elagawany M, Elmaaty AA, Mostafa A, Abo Shama NM, Santali EY, Elgendy B, Al-Karmalawy AA. Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease. J Enzyme Inhib Med Chem. 2022 Dec;37(1):2112-2132. doi: 10.1080/14756366.2022.2105322 © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Elagawany, Mohamed; Elmaaty, Ayman Abo; Mostafa, Ahmed; Abo Shama, Noura M; Santali, Eman Y; Elgendy, Bahaa; and Al-Karmalawy, Ahmed A, "Ligand-based design, synthesis, computational insights, and in vitro studies of novel N-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease." Journal of Enzyme Inhibition and Medicinal Chemistry. 37, 1. 2112 - 2132. (2022).
https://digitalcommons.wustl.edu/oa_4/295